We don't know for sure. The PR just states one die
Post# of 144548
![](/assets/46931549/no_avatar_available_thumb.jpg)
"CytoDyn released safety data on its experimental drug for Covid-19 on Tuesday, but efficacy data were conspicuously absent, and the company disclosed that a patient had died following treatment with the therapy."
From the PR:
"Of the 84 patients treated, one patient died 33 days after enrollment due to an event unrelated to leronlimab."
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)